You are here

Eli Lilly

What Lilly Expects for Revenue Growth in 2Q16

Market Realist

Tue, 07/19/16 - 10:08 pm

Which big biopharma companies put R&D as their top priority?

Endpoints

Mon, 07/18/16 - 09:46 am

Bristol-Myers Squibb

Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer

Yahoo

Wed, 07/13/16 - 09:46 am

Boehringer Ingelheim

clinical trials

metastatic breast cancer

Diabetes sales rocket toward $60B, with Novo and Lilly's GLP-1s first in line for growth

Fierce Pharma

Mon, 07/11/16 - 09:15 am

3 Potential Stock-Moving Drug Events In The Second Half Of 2016

Investors.com

Fri, 07/1/16 - 10:07 am

Alzheimer's disease

Gilead Sciences

U.S. panel backs claim Lilly diabetes drug cuts cardiac death

Yahoo/Reuters

Tue, 06/28/16 - 10:55 pm

advisory panels

Boehringer Ingelheim

Eli Lilly Launches Lantus Biosimilar To Boost Sales, But Not Without Risks

Seeking Alpha

Tue, 06/28/16 - 05:33 pm

Is Merck & Co., Inc Januvia In Trouble? FDA Panel Decides Tomorrow

Bidness, ETC

Mon, 06/27/16 - 03:13 pm

advisory panels

FDA panel to vote whether diabetes drug cuts cardiac death

Yahoo/Reuters

Fri, 06/24/16 - 04:06 pm

advisory panels

Boehringer Ingelheim

Eli Lilly Shows Terrific Innovation

Seeking Alpha

Thu, 06/23/16 - 09:18 am

How Big Is the Diabetes Treatment Market?

Motley Fool

Wed, 06/22/16 - 07:06 pm

Lilly execs: Net price pressures not a concern for new diabetes meds

Fierce Pharma

Tue, 06/21/16 - 11:28 am

Lilly and Boehringer's Jardiance sets new bar, shows kidney benefit

BioPharma Dive

Wed, 06/15/16 - 05:42 pm

Boehringer Ingelheim

New Jardiance® (empagliflozin) data show that reduced risk for cardiovascular (CV) death was consistent across age groups in adults with type 2 diabetes

Yahoo

Sun, 06/12/16 - 09:56 pm

type 2 diabetes

Boehringer Ingelheim

Baricitinib significantly reduces joint damage progression in rheumatoid arthritis in patients who do not respond to conventional DMARDs

Yahoo

Thu, 06/9/16 - 10:10 am

rheumatoid arthritis

3 Stories To Watch At The Year’s Biggest Cancer Conference

Investors.com

Mon, 05/30/16 - 06:34 pm

non-small cell lung cancer

Bristol-Myers Squibb

Bet You Can't Guess Which of These 10 Big Pharma Names Has the Largest Late-Stage Pipeline

Motley Fool

Mon, 05/30/16 - 10:13 am

Bristol-Myers Squibb

Pharma is gentrifying biotech’s hottest neighborhood, but some are mindful of displacing startups

Stat

Thu, 05/26/16 - 10:56 pm

[video]The Challenges Ahead for Eli Lilly

Bloomberg

Thu, 05/26/16 - 07:48 pm

Lilly says new type of pain drug could lessen need for opioids

Yahoo/Reuters

Tue, 05/24/16 - 11:40 pm

Pages